...
机译:H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer
Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland;
prostate cancer; hormonal therapy; androgens; enzalutamide; epigenetics;